Number of the records: 1  

Influence of the SARS-CoV-2 Omicron (B.1.1.529) variant and booster vaccine doses on the seroprevalence of specific IgG antibodies in the staff of the Slovak Academy of Sciences

  1. TitleInfluence of the SARS-CoV-2 Omicron (B.1.1.529) variant and booster vaccine doses on the seroprevalence of specific IgG antibodies in the staff of the Slovak Academy of Sciences
    Author Kajanová Ivana 1988 SAVBIOMED ; SAVVIR - Biomedicínske centrum SAV    ORCID
    Co-authors Jelenská Lenka 1982 SAVBIOMED ; SAVVIR - Biomedicínske centrum SAV

    Lukáčiková Ľubomíra 1984 SAVBIOMED ; SAVVIR - Biomedicínske centrum SAV

    Grossmannová Katarína 1985 SAVBIOMED ; SAVVIR - Biomedicínske centrum SAV

    Belisová Martina SAVBIOMED ; SAVVIR - Biomedicínske centrum SAV

    Ištvanová Nikola SAVBIOMED - Biomedicínske centrum SAV

    Gašparovičová Natália SAVBIOMED - Biomedicínske centrum SAV

    Zelník Vladimír 1962 SAVBIOMED - Biomedicínske centrum SAV

    Pastoreková Silvia 1961 SAVBIOMED ; SAVVIR - Biomedicínske centrum SAV    ORCID

    Rádiková Žofia SAVBIOMED ; SAVUKTRA - Biomedicínske centrum SAV    ORCID

    Kopáček Juraj 1963 SAVBIOMED ; SAVVIR - Biomedicínske centrum SAV    ORCID

    Source document Acta Virologica. Vol. 67, June (2023), art. no. 11637
    Languageeng - English
    CountrySK - Slovak Republic
    Noteopen access
    URLURL link
    Document kindrozpis článkov z periodík (rbx)
    CategoryADDA - Scientific papers in domestic journals registered in Current Contents Connect with IF (impacted)
    Category of document (from 2022)V3 - Vedecký výstup publikačnej činnosti z časopisu
    Type of documentčlánok
    Year2023
    Registered inWOS
    Registered inCCC
    DOI 10.3389/av.2023.11637
    article

    article

    rokCCIFIF Q (best)JCR Av Jour IF PercSJRSJR Q (best)CiteScore
    A
    rok vydaniarok metrikyIFIF Q (best)SJRSJR Q (best)
    202320221.7Q40.31Q3
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.